IL130160A0 - Inactivation of HIV co-receptors as therapy for HIV infection - Google Patents
Inactivation of HIV co-receptors as therapy for HIV infectionInfo
- Publication number
- IL130160A0 IL130160A0 IL13016097A IL13016097A IL130160A0 IL 130160 A0 IL130160 A0 IL 130160A0 IL 13016097 A IL13016097 A IL 13016097A IL 13016097 A IL13016097 A IL 13016097A IL 130160 A0 IL130160 A0 IL 130160A0
- Authority
- IL
- Israel
- Prior art keywords
- hiv
- inactivation
- receptors
- therapy
- infection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3227796P | 1996-12-02 | 1996-12-02 | |
PCT/US1997/022198 WO1998024923A1 (en) | 1996-12-02 | 1997-12-02 | Inactivation of hiv co-receptors as therapy for hiv infection |
Publications (1)
Publication Number | Publication Date |
---|---|
IL130160A0 true IL130160A0 (en) | 2000-06-01 |
Family
ID=21864069
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13016097A IL130160A0 (en) | 1996-12-02 | 1997-12-02 | Inactivation of HIV co-receptors as therapy for HIV infection |
IL130160A IL130160A (en) | 1996-12-02 | 1999-05-27 | Expression vector for blocking hiv entry into a cell and compositions comprising cells transduced with such vector |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL130160A IL130160A (en) | 1996-12-02 | 1999-05-27 | Expression vector for blocking hiv entry into a cell and compositions comprising cells transduced with such vector |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0963441A4 (xx) |
JP (1) | JP2001505055A (xx) |
AU (1) | AU721121B2 (xx) |
CA (1) | CA2273192A1 (xx) |
IL (2) | IL130160A0 (xx) |
WO (1) | WO1998024923A1 (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030049251A1 (en) * | 1999-12-08 | 2003-03-13 | Barbas Carlos F. | Methods and compositions useful for inhibiting ccr5-dependent infection of cells by hiv-1 |
ES2442615T5 (es) | 2002-07-18 | 2023-03-16 | Merus Nv | Producción recombinante de mezclas de anticuerpos |
USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
EP1639009B1 (en) | 2003-05-30 | 2013-02-27 | Merus B.V. | Fab library for the preparation of a mixture of antibodies |
US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
NZ630551A (en) | 2012-04-20 | 2017-11-24 | Merus Nv | Methods and means for the production of ig-like molecules |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69521331T2 (de) * | 1994-11-01 | 2001-09-20 | Winfried Wels | Nukleinsäure-einbringungssystem |
JP2001504334A (ja) * | 1996-11-06 | 2001-04-03 | アメリカ合衆国 | プロテアーゼ活性化可能なPseudomonas体外毒素A様プロタンパク質 |
US6100387A (en) * | 1997-02-28 | 2000-08-08 | Genetics Institute, Inc. | Chimeric polypeptides containing chemokine domains |
US6214540B1 (en) * | 1997-03-26 | 2001-04-10 | University Of Maryland Biotechnology Institute | Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
GB9718609D0 (en) * | 1997-09-02 | 1997-11-05 | Imp College Innovations Ltd | Fusion protein |
MXPA00003885A (es) * | 1997-10-22 | 2004-04-23 | Inst Genetics Llc | Quimiocinas con modificiaciones de la terminacion amino. |
US6110695A (en) * | 1997-12-02 | 2000-08-29 | The Regents Of The University Of California | Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1 |
-
1997
- 1997-12-02 CA CA002273192A patent/CA2273192A1/en not_active Abandoned
- 1997-12-02 JP JP52495998A patent/JP2001505055A/ja active Pending
- 1997-12-02 EP EP97950829A patent/EP0963441A4/en not_active Withdrawn
- 1997-12-02 AU AU53724/98A patent/AU721121B2/en not_active Ceased
- 1997-12-02 WO PCT/US1997/022198 patent/WO1998024923A1/en not_active Application Discontinuation
- 1997-12-02 IL IL13016097A patent/IL130160A0/xx active IP Right Grant
-
1999
- 1999-05-27 IL IL130160A patent/IL130160A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0963441A4 (en) | 2002-10-02 |
WO1998024923A1 (en) | 1998-06-11 |
CA2273192A1 (en) | 1998-06-11 |
JP2001505055A (ja) | 2001-04-17 |
IL130160A (en) | 2007-07-04 |
EP0963441A1 (en) | 1999-12-15 |
AU721121B2 (en) | 2000-06-22 |
AU5372498A (en) | 1998-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA944488B (en) | System for viral inactivation of blood | |
ZA954436B (en) | Process of sterilization | |
ZA906621B (en) | Use of viruses against undesirable micro-organisms | |
AU7973994A (en) | Combination therapy for hiv infection | |
AUPM761094A0 (en) | Treatment of hides | |
AU5157998A (en) | Methods and compositions for treatment of hepatitis c infection | |
AU3474593A (en) | Hypericin treatment of vaccine agents for improved immunogenicity | |
IL130160A0 (en) | Inactivation of HIV co-receptors as therapy for HIV infection | |
AU7717396A (en) | Inactivation of pathogens using hydroxymethylamines | |
ZA96722B (en) | Combination therapy for hiv infection | |
AU4602897A (en) | Method for treatment of immunodeficiency virus infection | |
HU9603567D0 (en) | Combination therapy for hiv infection | |
AU3530395A (en) | Treatment of viral infections | |
HUP0100365A3 (en) | Combination therapy for the treatment of aids | |
AU4604697A (en) | Compositions and methods for the treatment of human cytomegalovirus infection | |
GB9317943D0 (en) | Treatment of laminitis | |
AU1389897A (en) | Use of chemokines for the treatment and prevention of hiv infection | |
GB9508300D0 (en) | HIV protease inhibtors for the treatment of aids | |
AU5419894A (en) | Dental treatment aid | |
AU1979397A (en) | Peptidomimetics for the treatment of hiv infection | |
AU4219799A (en) | Combination therapy for treatment of fiv infection | |
AU2732297A (en) | Benzamide treatment of dementia associated with aids virus (hiv-1) infection | |
ZA956662B (en) | Combination therapy for HIV infection | |
GB9725478D0 (en) | Treatment of cotton | |
ZA981198B (en) | Treatment of hiv positive patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |